首页> 美国卫生研究院文献>Bioinorganic Chemistry and Applications >Bioinorganic Chemistry in Thyroid Gland: Effect ofAntithyroid Drugs on Peroxidase-Catalyzed Oxidation and Iodination Reactions
【2h】

Bioinorganic Chemistry in Thyroid Gland: Effect ofAntithyroid Drugs on Peroxidase-Catalyzed Oxidation and Iodination Reactions

机译:甲状腺中的生物无机化学:的影响抗甲状腺药物对过氧化物酶催化的氧化和碘化反应的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Propylthiouracil (PTU) and methimazole (MMI) are the most commonly used antithyroid drugs. The available data suggest that these drugs may block the thyroid hormone synthesis by inhibiting the thyroid peroxidase (TPO) or diverting oxidized iodides away from thyroglobulin. It is also known that PTU inhibits the selenocysteine-containing enzyme ID-1 by reacting with the selenenyl iodide intermediate (E-SeI). In view of the current interest in antithyroid drugs, we have recently carried out biomimetic studies to understand the mechanism by which the antithyroid drugs inhibit the thyroid hormone synthesis and found that the replacement of sulfur with selenium in MMI leads to an interesting compound that may reversibly block the thyroid hormone synthesis. Our recent results on the inhibition of lactoperoxidase (LPO)-catalyzed oxidation and iodination reactions by antithyroid drugs are described.
机译:丙硫氧嘧啶(PTU)和甲巯咪唑(MMI)是最常用的抗甲状腺药物。现有数据表明,这些药物可通过抑制甲状腺过氧化物酶(TPO)或将氧化碘从甲状腺球蛋白中转移出去,从而阻断甲状腺激素的合成。还已知PTU通过与硒烯基碘化物中间体(E-SeI)反应来抑制含硒代半胱氨酸的酶ID-1。鉴于目前对抗甲状腺药物的兴趣,我们最近进行了仿生研究,以了解抗甲状腺药物抑制甲状腺激素合成的机制,并发现MMI中的硒替代硒会产生有趣的化合物,该化合物可能可逆阻断甲状腺激素的合成。我们最近对抗甲状腺药物抑制乳过氧化物酶(LPO)催化的氧化和碘化反应的结果进行了描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号